Physician profile
Joshua E Danley
NPI 1790918803
$4,248.67
in general payments reported to CMS, 2019-2025
30 companies · $428 in 2025
The $428 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $750 · 2020: $247 · 2021: $418 · 2022: $912 · 2023: $850 · 2024: $645 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,922.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $767.47 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Insmed, INC. | $631.93 | 2019-2024 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $404.01 | 2019-2025 | Ofev, Jascayd |
| Janssen Pharmaceuticals, INC | $269.66 | 2020-2022 | |
| Astrazeneca Pharmaceuticals Lp | $257.58 | 2019-2025 | Imfinzi, Fasenra, Breztri |
| Genzyme Corporation | $231.35 | 2019-2023 | |
| Axsome Therapeutics, INC. | $201.32 | 2023 | Sunosi |
| United Therapeutics Corporation | $191.20 | 2019-2024 | Tyvaso |
| Actelion Pharmaceuticals US, INC. | $146.23 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $136.03 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $132.57 | 2019-2023 | |
| Inspire Medical Systems, INC. | $119.75 | 2024-2025 | Inspire |
| Grifols USA, LLC | $113.40 | 2019 | |
| Mylan Specialty L.P. | $101.37 | 2019-2022 | |
| Pfizer INC. | $88.90 | 2021-2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $63.01 | 2019-2024 | (Ak6) Vest Therapy |
| Mallinckrodt Hospital Products INC. | $53.72 | 2022 | |
| Electromed, INC. | $43.88 | 2024 | Smartvest |
| Abbvie INC. | $42.09 | 2023 | Teflaro, Avycaz |
| Resmed Corp | $31.03 | 2019 | |
| Sunovion Pharmaceuticals INC. | $29.41 | 2019 | |
| Harmony Biosciences LLC | $28.07 | 2022 | |
| Viatris Specialty LLC | $26.82 | 2025 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $23.57 | 2023 | Camzyos |
| Advanced Respiratory, INC | $23.19 | 2020 | |
| Inogen, INC. | $21.67 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Novo Nordisk INC | $20.05 | 2022 | |
| Mallinckrodt Enterprises LLC | $18.51 | 2019 | |
| Genentech USA, INC. | $17.49 | 2019 | |
| Vapotherm INC | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Danley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.